Definition: HL7 in the laboratory context
In North American and many international hospitals, HL7 v2 messages carry operational truth: who the patient is, what was ordered, what specimen was collected, and what resulted. A LIS is responsible for translating those messages into accessioning, instrument worklists, technical validation, and final sign-out.
HL7 is not a substitute for a project plan. Successful HL7 LIS integration requires agreement on message types (for example ADT, ORM, ORU), segment usage, identifier namespaces (MRN vs accession), and exception handling when messages fail validation.
Typical workflow: order to verified result
A common pattern begins with an electronic order originating in the EHR or order comm module. The order message is received by the LIS, matched to the laboratory test dictionary, and drives accessioning and collection lists. Specimens are tracked through pre-analytical steps; analytical results are released only after QC and rule-based checks complete.
When results are finalized, an HL7 result message returns to the consuming system with coded observations and narrative where required. The LIS should preserve an auditable linkage between inbound orders, internal modifications, and outbound results.
Implementation checklist for interface teams
- Inventory systems: identify sending/receiving applications, message versions, and transport (MLLP, VPN, TLS endpoints).
- Freeze the test dictionary: map order codes to LIS procedures, including reflex and panel rules.
- Define duplicate detection: decide how to handle re-draws, add-on orders, and corrected results.
- Logging and replay: ensure operations can inspect queue depth, dead-letter queues, and per-interface latency.
- Parallel run: compare HL7-fed results against legacy interfaces until error rates meet agreed thresholds.
Interoperability with analyzers (HL7 vs ASTM)
Hospital-facing integration is frequently HL7, while point-to-point analyzer traffic may use ASTM E1381/E1394-style framing or vendor-specific transports. Medrara is architected to support both families of interfaces where deployed and configured; your integration profile depends on analyzer capability and network segmentation.
Governance, privacy, and auditability
US-facing deployments should align interface design with HIPAA Security Rule expectations: least-privilege service accounts, encrypted channels, and documented change control. EU/UK deployments add GDPR considerations for lawful basis and data minimization in messages. The LIS should expose role-based access and audit trails for message reprocessing and manual overrides.
How Medrara fits
Medrara is a cloud LIS intended for organizations that need centralized master data, multi-site permissions, and standards-based connectivity. HL7 work is treated as a joint deliverable between your hospital IT, middleware vendor (if any), and laboratory operations—not a checkbox feature.
جدول مقارنة
Illustrative comparison for planning discussions (not vendor-specific benchmarks).
| Topic | HL7-centric hospital integration | Point-to-point analyzer links |
|---|---|---|
| Primary goal | Align clinical orders and documented results | Automate instrument upload/download |
| Typical owner | Hospital IT + integration engine | Laboratory operations + instrument vendor |
| Governance | ADT/ORU contracts, code sets, release management | Frame specs, checksums, mapping tables |
الأسئلة الشائعة
Does Medrara ship with a fixed HL7 profile?
No. HL7 profiles vary by hospital vendor, version, and site-specific conventions. Medrara supports configurable integration paths; your project team defines the profile with your IT stakeholders.
Can we run HL7 interfaces in parallel with legacy systems?
Yes. Parallel operation is recommended during mapping validation and user acceptance testing to reduce cutover risk.
Who owns message mapping maintenance?
Typically laboratory informatics owns the test dictionary while hospital IT owns ADT feeds and network endpoints. Contracts should name responsible parties for break/fix and regression testing after upgrades.